The Prevalence of Chronic Critical Lower Limb Ischaemia in a Population of 20,000 Subjects 40-69 Years of Age

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 1, 2006, Pages 60-65

  Jensen, S A ^a,b   Vatten, L J ^a   Myhre, H O ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Association; Epidemiology; Peripheral arterial disease; Population study; Prevalence

Indexed keywords

GLUCOSE; LIPID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANGINA PECTORIS; ANKLE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; FOOT PAIN; FOOT ULCER; GLUCOSE BLOOD LEVEL; HEALING IMPAIRMENT; HUMAN; LIMB ISCHEMIA; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SUPINE POSITION; TOE;

ADULT; AGE FACTORS; AGED; ANGINA PECTORIS; BODY MASS INDEX; CHRONIC DISEASE; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; FEMALE; HEALTH SURVEYS; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; NORWAY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 33744931925     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.12.022     Document Type: Article

References (38)

1. Dormandy J., Heeck L., and Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg 12 (1999) 142-147
2. Dormandy J., Heeck L., and Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 12 (1999) 123-137
3. Dormandy J.A., and Murray G.D. The fate of the claudicant-a prospective study of 1969 claudicants. Eur J Vasc Surg 5 (1991) 131-133
4. Mätzke S., and Lepäntalo M. Claudication does not always precede critical leg ischaemia. Vasc Med 6 (2001) 77-80
5. Fontaine R., Kim M., and Kieny R. Die chirurgische Behandlung der peripheren Durchblutungsstörungen. Helv Chir Acta 21 5-6 (1954) 499-533
6. Myhre H.O., and Witsø E. What are the costs of critical limb ischaemia?. Critical Ischaemia 5 (1995) 83-87
7. Myhre H., Fosby B., Witsø E., and Groechenig E. Cost-effectiveness of therapeutic options for critical limb ischaemia. Critical Ischaemia 6 (1996) 37-41
8. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
9. Luther M., Kantonen I., Lepäntalo M., Salenius J., and Group K.Y. Arterial intervention and reduction in amputation for chronic critical leg ischaemia. Br J Surg 87 (2000) 454-458
10. Wolfe J.H.N. Defining the outcome of critical ischaemia. A one year prospective study. Br J Surg 73 (1986) 321
11. Carter S.A. The challenge and importance of defining critical limb ischemia. Vasc Med 2 (1997) 126-131
12. Catalano M. Epidemiology of critical limb ischaemia: North Italian data. Eur J Med 2 (1993) 11-14
13. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31 (2000) S1-S296
14. Critical ischaemia of the limbs. Consensus meeting of the European Working Group "Critical Limb Ischaemia", 9-11 March 1989. Klin Wochenschr 1989;67(suppl. 14):1-16.
15. European Working Group on Critical Limb Ischaemia. Second European consensus document on chronic critical leg ischaemia. Circulation 84 Suppl (1991) 1-26
16. Myhre H.O., Sæther O.D., and Mathisen S.R. The epidemiology of critical limb ischaemia. Critical Ischaemia 3 Suppl 1 (1993) 25-29
17. Harris P.L., Da Silva A.F., Holdsworth J., McCollum P., Jones S.M., Beard J., et al. Critical limb ischaemia: management and outcome. Report of a national survey. The Vascular Surgical Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg 10 (1995) 108-113
18. Criqui M.H., Denenberg J.O., Langer R.D., and Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 2 (1997) 221-226
19. Rutherford R.B., Flanigan D.P., Gupta S.K., Johnston K.W., Karmody A., Whittemore A.D., et al. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 4 (1986) 80-94
20. Bertele V., Avanzini F., Colombo F., De Gactano G., Fellin G., Pangrazzi J., et al. A prospective epidemiological survey of the natural history of chronic critical leg ischaemia. The ICAI Group (gruppo di studio dell'ischemia cronica critica degli arti inferiori). Eur J Vasc Endovasc Surg 11 (1996) 112-120
21. Holmen J., Midthjell K., Krüger Ø., et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 13 (2003) 19-32. http://www.medisin.ntnu.no/nofe/norepid/ [http://www.medisin.ntnu.no/nofe/norepid/]
22. National Institute of Health, National Heart and Lung Institute. Manual of laboratory operations: lipid research clinics program. Lipid and lipoprotein analysis vol. 1 (1975) p. 75-628
23. Thompson M.M., Sayers R.D., Varty K., Reid A., London N.J., Bell P.R., et al. Chronic critical leg ischaemia must be redefined. Eur J Vasc Surg 7 (1993) 420-426
24. Eickhoff J.H., Hansen H.J., and Lorentzen J.E. The effect of arterial reconstruction on lower limb amputation rate. An epidemiological survey based on reports from Danish hospitals. Acta Chir Scand Suppl 502 (1980) 181-187
25. Liedberg E., and Persson B.M. Age, diabetes and smoking in lower limb amputation for arterial occlusive disease. Acta Orthop Scand 54 (1983) 383-388
26. Da Silva A., Widmer L.K., Ziegler H.W., Nissen C., and Schweizer W. The Basle longitudinal study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. J Chronic Dis 32 (1979) 797-803
27. Kannel W.B., and Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics 28 (1973) 61-68
28. McGrath M.A., Graham A.R., Hill D.A., Lord R.S., and Tracy G.D. The natural history of chronic leg ischemia. World J Surg 7 (1983) 314-318
29. Wells A.J., English P.B., Posner S.F., Wagenknecht L.E., and Perez-Stable E.J. Misclassification rates for current smokers misclassified as nonsmokers. Am J Public Health 88 (1998) 1503-1509
30. Pell J.P., Fowkes F.G., and Lee A.J. Indications for arterial reconstruction and major amputation in the management of chronic critical lower limb ischaemia. The Scottish and Northern Vascular Audit Groups. Eur J Vasc Endovasc Surg 13 (1997) 315-321
31. Kannel W.B. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1 (1994) 333-339
32. Christensen S. Lower extremity amputations in the county of Aalborg 1961-1971. Acta Orthop Scand 47 (1976) 329-334
33. Collins R., Armitage J., Parish S., Sleight P., Peto R., et al. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
34. Balkau B. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol 23 Suppl 3 (1994) S8-S16
35. Cimminiello C. PAD. Epidemiology and pathophysiology. Thromb Res 106 (2002) V295-V301
36. Jensen S.A., Vatten L.J., Romundstad P.R., and Myhre H.O. Serum lipids and anthropometric factors related to the prevalence of intermittent claudication. Eur J Vasc Endovasc Surg 30 (2005) 582-587
37. Bell P., Charlesworth D., and DePalma R.G. The definition of critical ischaemia of a limb. Br J Surg 69 (1982) 1117-1119
38. Skrede K, Brunborg H, Hetland A, Keilman N, Nymoen E. Population projections. National and regional figures 1999-2050. Statistics Norway; 1999. http://www.ssb.no/english/subjects/02/03/folkfram-en/